Explore

Trendline Trendline
Forlong Completes Phase I Trials of FL115 for Advanced Solid Tumors with Promising Results

Forlong Completes Phase I Trials of FL115 for Advanced Solid Tumors with Promising Results

Forlong Completes Phase I Trials of FL115 for Advanced Solid Tumors with Promising Results
Trendline Trendline
Ankyra Therapeutics Presents Novel IL-12 Anchored Immunotherapy at ASCO 2026

Ankyra Therapeutics Presents Novel IL-12 Anchored Immunotherapy at ASCO 2026

Ankyra Therapeutics Presents Novel IL-12 Anchored Immunotherapy at ASCO 2026
Trendline Trendline
Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval

Brenus Pharma's Immunotherapy for Colorectal Cancer Receives FDA IND Approval
Trendline Trendline
Forlong Biotechnology Completes Phase I Trials of FL115 for Advanced Tumors

Forlong Biotechnology Completes Phase I Trials of FL115 for Advanced Tumors

Forlong Biotechnology Completes Phase I Trials of FL115 for Advanced Tumors
Trendline Trendline
Ankyra Therapeutics to Present Novel IL-12 Anchored Immunotherapy at ASCO 2026

Ankyra Therapeutics to Present Novel IL-12 Anchored Immunotherapy at ASCO 2026

Ankyra Therapeutics to Present Novel IL-12 Anchored Immunotherapy at ASCO 2026
Trendline Trendline
BeOne Medicines Reveals Phase 3 HERIZON-GEA Trial Results with Significant Survival Benefits

BeOne Medicines Reveals Phase 3 HERIZON-GEA Trial Results with Significant Survival Benefits

BeOne Medicines Reveals Phase 3 HERIZON-GEA Trial Results with Significant Survival Benefits
Trendline Trendline
Solu Therapeutics Receives FDA Fast Track Designation for STX-0712 in Leukemia Treatment

Solu Therapeutics Receives FDA Fast Track Designation for STX-0712 in Leukemia Treatment

Solu Therapeutics Receives FDA Fast Track Designation for STX-0712 in Leukemia Treatment
Trendline Trendline
Brenus Pharma's STC-1010 Receives FDA IND Approval for Colorectal Cancer

Brenus Pharma's STC-1010 Receives FDA IND Approval for Colorectal Cancer

Brenus Pharma's STC-1010 Receives FDA IND Approval for Colorectal Cancer
Trendline Trendline
Archeus Technologies Begins Phase 1 Trial for Metastatic Cancer Treatment

Archeus Technologies Begins Phase 1 Trial for Metastatic Cancer Treatment

Archeus Technologies Begins Phase 1 Trial for Metastatic Cancer Treatment
Trendline Trendline
Genprex Publishes Positive Biomarker Data for Reqorsa Gene Therapy at ASCO 2026

Genprex Publishes Positive Biomarker Data for Reqorsa Gene Therapy at ASCO 2026

Genprex Publishes Positive Biomarker Data for Reqorsa Gene Therapy at ASCO 2026
Trendline Trendline
Citius Oncology Presents Promising Phase 1 Data on LYMPHIR at ASCO Meeting

Citius Oncology Presents Promising Phase 1 Data on LYMPHIR at ASCO Meeting

Citius Oncology Presents Promising Phase 1 Data on LYMPHIR at ASCO Meeting
Trendline Trendline
Archeus Technologies Begins Phase 1 Trial for ARC-706 in Metastatic Cancer

Archeus Technologies Begins Phase 1 Trial for ARC-706 in Metastatic Cancer

Archeus Technologies Begins Phase 1 Trial for ARC-706 in Metastatic Cancer